1
|
Wang Y, Schill KM, Fry HC, Duncan TV. A Quantum Dot Nanobiosensor for Rapid Detection of Botulinum Neurotoxin Serotype E. ACS Sens 2020; 5:2118-2127. [PMID: 32527082 DOI: 10.1021/acssensors.0c00738] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Botulinum neurotoxins (BoNTs) are potent toxins produced by Clostridium bacteria that are responsible for the illness botulism and are listed as bioterrorism agents. BoNT serotype E (BoNT/E) is one of four BoNT serotypes that cause human botulism and is the second most frequent cause of foodborne botulism. Rapid detection and discrimination of BoNT serotypes implicated in human disease are critical for ensuring timely treatment of patients and identifying sources of toxins, but there have been few reported detection methods for BoNT/E and even fewer methods usable for BoNT serotyping. We report a nanobiosensor based on Förster resonance energy transfer (FRET) between semiconductor nanocrystals (quantum dots, QDs) and dark quencher-labeled peptide probes to detect biologically active BoNT/E in aqueous media. The peptide probes contain a specific cleavage site for active BoNT/E. QD photoluminescence, which changes intensity due to FRET when the peptide probe is cleaved, was used to indicate toxin presence and quantity. The detection of a BoNT/E light chain (LcE) and holotoxin was observed within 3 h. The limits of detection were 0.02 and 2 ng/mL for LcE and holotoxin, respectively. The nanobiosensor shows good specificity toward the target in tests with nontarget BoNT serotypes. The high sensitivity, simple operation, short detection time, and ability to be used in parallel with probes developed for other BoNT serotypes indicate that the nanobiosensor will be useful for rapid BoNT/E detection and serotype discrimination in food analysis.
Collapse
Affiliation(s)
- Yun Wang
- Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Bedford Park, Illinois 60501, United States
| | - Kristin M. Schill
- Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Bedford Park, Illinois 60501, United States
| | - H. Christopher Fry
- Center for Nanoscale Materials, Argonne National Laboratory, DuPage County, Illinois 60439, United States
| | - Timothy V. Duncan
- Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Bedford Park, Illinois 60501, United States
| |
Collapse
|
2
|
Nepal MR, Jeong TC. Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives. Biomol Ther (Seoul) 2020; 28:302-310. [PMID: 32126735 PMCID: PMC7327137 DOI: 10.4062/biomolther.2019.200] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Revised: 02/06/2020] [Accepted: 02/17/2020] [Indexed: 01/29/2023] Open
Abstract
Botulinum toxins are neurotoxic modular proteins composed of a heavy chain and a light chain connected by a disulfide bond and are produced by Clostridium botulinum. Although lethally toxic, botulinum toxin in low doses is clinically effective in numerous medical conditions, including muscle spasticity, strabismus, hyperactive urinary bladder, excessive sweating, and migraine. Globally, several companies are now producing products containing botulinum toxin for medical and cosmetic purposes, including the reduction of facial wrinkles. To test the efficacy and toxicity of botulinum toxin, animal tests have been solely and widely used, resulting in the inevitable sacrifice of hundreds of animals. Hence, alternative methods are urgently required to replace animals in botulinum toxin testing. Here, the various alternative methods developed to test the toxicity and efficacy of botulinum toxins have been briefly reviewed and future perspectives have been detailed.
Collapse
Affiliation(s)
- Mahesh Raj Nepal
- College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea
| | - Tae Cheon Jeong
- College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea
| |
Collapse
|
3
|
Lim CY, Granger JH, Porter MD. SERS detection of Clostridium botulinum neurotoxin serotypes A and B in buffer and serum: Towards the development of a biodefense test platform. Anal Chim Acta X 2018; 1:100002. [PMID: 33186413 PMCID: PMC7587037 DOI: 10.1016/j.acax.2018.100002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Accepted: 12/10/2018] [Indexed: 01/30/2023] Open
Abstract
Botulinum neurotoxins (BoNTs) are classified at a highest degree of threat in biodefense, due largely to their high lethality. With the growing risk of biowarfare, the shortcomings of the gold standard test for these neurotoxins, the mouse bioassay, have underscored the need to develop alternative diagnostic testing strategies. This paper reports on the detection of inactivated Clostridium botulinum neurotoxin serotype A (BoNT-A) and serotype B (BoNT-B), the two most important markers of botulism infection, by using a sandwich immunoassay, gold nanoparticle labels, and surface-enhanced Raman scattering (SERS) within the context of two threat scenarios. The first scenario mimics part of the analysis needed in response to a “white powder” threat by measuring both neurotoxins in phosphate-buffered saline (PBS), a biocompatible solvent often used to recover markers dispersed in a powdered matrix. The second scenario detects the two neurotoxins in spiked human serum to assess the clinical potential of the platform. The overall goal is to develop a test applicable to both scenarios in terms of projections of required levels of detection. We demonstrate the ability to measure BoNT-A and BoNT-B in PBS at a limit of detection (LoD) of 700 pg/mL (5 pM) and 84 pg/mL (0.6 pM), respectively, and in human serum at 1200 pg/mL (8 pM) and 91 pg/mL (0.6 pM), respectively, with a time to result under 24 h. The steps required to transform this platform into an onsite biodefense screening tool that can simultaneously and rapidly detect (<1 h) these and other agents are briefly discussed. Raman-based immunoassays can successfully detect botulism neurotoxins. Limits of detection for botulism neurotoxins A/B rival those of the mouse bioassay. Serum and liquid extracts are suitable sample matrices for the Raman assay.
Collapse
Affiliation(s)
- China Y Lim
- Department of Chemical Engineering, University of Utah, Salt Lake City, UT, 84112-5001, USA
| | - Jennifer H Granger
- Nano Institute of Utah, University of Utah, Salt Lake City, UT, 84112-5001, USA
| | - Marc D Porter
- Department of Chemical Engineering, University of Utah, Salt Lake City, UT, 84112-5001, USA.,Nano Institute of Utah, University of Utah, Salt Lake City, UT, 84112-5001, USA.,Department of Chemistry, University of Utah, Salt Lake City, UT, 84112-5001, USA
| |
Collapse
|
4
|
Hansbauer EM, Skiba M, Endermann T, Weisemann J, Stern D, Dorner MB, Finkenwirth F, Wolf J, Luginbühl W, Messelhäußer U, Bellanger L, Woudstra C, Rummel A, Fach P, Dorner BG. Detection, differentiation, and identification of botulinum neurotoxin serotypes C, CD, D, and DC by highly specific immunoassays and mass spectrometry. Analyst 2016; 141:5281-97. [PMID: 27353114 DOI: 10.1039/c6an00693k] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Botulinum neurotoxin (BoNT) serotypes C and D and their mosaic variants CD and DC cause severe cases of botulism in animal husbandry and wildlife. Epidemiological data on the exact serotype or toxin variant causing outbreaks are rarely available, mainly because of their high sequence identity and the lack of fast and specific screening tools to detect and differentiate the four similar toxins. To fill this gap, we developed four highly specific sandwich enzyme-linked immunosorbent assays (ELISAs) able to detect and differentiate botulinum neurotoxins type BoNT/C, D, CD, and DC based on four distinct combinations of specific monoclonal antibodies targeting both conserved and divergent subdomains of the four toxins. Here, highly sensitive detection with detection limits between 2 and 24 pg mL(-1) was achieved. The ELISAs were extensively validated and results were compared with data obtained by quantitative real-time PCR using a panel of Clostridium botulinum strains, real sample materials from veterinary botulism outbreaks, and non-BoNT-producing Clostridia. Additionally, in order to verify the results obtained by ELISA screening, the new monoclonal antibodies were used for BoNT enrichment and subsequent detection (i) on a functional level by endopeptidase mass spectrometry (Endopep-MS) assays and (ii) on a protein sequence level by LC-MS/MS spectrometry. Based on all technical information gathered in the validation study, the four differentiating ELISAs turned out to be highly reliable screening tools for the rapid analysis of veterinary botulism cases and should aid future field investigations of botulism outbreaks and the acquisition of epidemiological data.
Collapse
Affiliation(s)
- Eva-Maria Hansbauer
- Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute (RKI), Berlin, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
|
6
|
Zhao Q, Huang H, Zhang L, Wang L, Zeng Y, Xia X, Liu F, Chen Y. Strategy To Fabricate Naked-Eye Readout Ultrasensitive Plasmonic Nanosensor Based on Enzyme Mimetic Gold Nanoclusters. Anal Chem 2015; 88:1412-8. [DOI: 10.1021/acs.analchem.5b04089] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Qian Zhao
- Key
Laboratory of Theoretical Organic Chemistry and Function Molecule,
Ministry of Education, Hunan Provincial University Key Laboratory of QSAR/QSPR, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, China
| | - Haowen Huang
- Key
Laboratory of Theoretical Organic Chemistry and Function Molecule,
Ministry of Education, Hunan Provincial University Key Laboratory of QSAR/QSPR, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, China
| | - Lingyang Zhang
- Key
Laboratory of Theoretical Organic Chemistry and Function Molecule,
Ministry of Education, Hunan Provincial University Key Laboratory of QSAR/QSPR, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, China
| | - Linqian Wang
- Department
of Medical Laboratory, Hunan Cancer Hospital, the Affiliated Cancer
Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan Province China
| | - Yunlong Zeng
- Key
Laboratory of Theoretical Organic Chemistry and Function Molecule,
Ministry of Education, Hunan Provincial University Key Laboratory of QSAR/QSPR, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, China
| | - Xiaodong Xia
- Key
Laboratory of Theoretical Organic Chemistry and Function Molecule,
Ministry of Education, Hunan Provincial University Key Laboratory of QSAR/QSPR, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, China
| | - Fengping Liu
- Key
Laboratory of Theoretical Organic Chemistry and Function Molecule,
Ministry of Education, Hunan Provincial University Key Laboratory of QSAR/QSPR, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, China
| | - Yi Chen
- Key
Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China
| |
Collapse
|
7
|
Simon S, Fiebig U, Liu Y, Tierney R, Dano J, Worbs S, Endermann T, Nevers MC, Volland H, Sesardic D, Dorner MB. Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples. Toxins (Basel) 2015; 7:5011-34. [PMID: 26703727 PMCID: PMC4690110 DOI: 10.3390/toxins7124860] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2015] [Revised: 11/03/2015] [Accepted: 11/04/2015] [Indexed: 12/16/2022] Open
Abstract
Botulinum neurotoxins (BoNTs) cause the life-threatening neurological illness botulism in humans and animals and are divided into seven serotypes (BoNT/A–G), of which serotypes A, B, E, and F cause the disease in humans. BoNTs are classified as “category A” bioterrorism threat agents and are relevant in the context of the Biological Weapons Convention. An international proficiency test (PT) was conducted to evaluate detection, quantification and discrimination capabilities of 23 expert laboratories from the health, food and security areas. Here we describe three immunological strategies that proved to be successful for the detection and quantification of BoNT/A, B, and E considering the restricted sample volume (1 mL) distributed. To analyze the samples qualitatively and quantitatively, the first strategy was based on sensitive immunoenzymatic and immunochromatographic assays for fast qualitative and quantitative analyses. In the second approach, a bead-based suspension array was used for screening followed by conventional ELISA for quantification. In the third approach, an ELISA plate format assay was used for serotype specific immunodetection of BoNT-cleaved substrates, detecting the activity of the light chain, rather than the toxin protein. The results provide guidance for further steps in quality assurance and highlight problems to address in the future.
Collapse
Affiliation(s)
- Stéphanie Simon
- CEA Saclay, Institute of Biology and Technologies of Saclay, Laboratory for Immunoanalytical Researches, Gif-sur-Yvette 91191 cedex, France.
| | - Uwe Fiebig
- Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestrasse 10, 13353 Berlin, Germany.
| | - Yvonne Liu
- Division of Bacteriology, National Institute for Biological Standards and Control, a Centre of Medicines & Healthcare Products Regulatory Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.
| | - Rob Tierney
- Division of Bacteriology, National Institute for Biological Standards and Control, a Centre of Medicines & Healthcare Products Regulatory Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.
| | - Julie Dano
- CEA Saclay, Institute of Biology and Technologies of Saclay, Laboratory for Immunoanalytical Researches, Gif-sur-Yvette 91191 cedex, France.
| | - Sylvia Worbs
- Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestrasse 10, 13353 Berlin, Germany.
| | - Tanja Endermann
- Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestrasse 10, 13353 Berlin, Germany.
| | - Marie-Claire Nevers
- CEA Saclay, Institute of Biology and Technologies of Saclay, Laboratory for Immunoanalytical Researches, Gif-sur-Yvette 91191 cedex, France.
| | - Hervé Volland
- CEA Saclay, Institute of Biology and Technologies of Saclay, Laboratory for Immunoanalytical Researches, Gif-sur-Yvette 91191 cedex, France.
| | - Dorothea Sesardic
- Division of Bacteriology, National Institute for Biological Standards and Control, a Centre of Medicines & Healthcare Products Regulatory Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.
| | - Martin B Dorner
- Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestrasse 10, 13353 Berlin, Germany.
| |
Collapse
|
8
|
Yao C, Wang T, Zhang B, He D, Na N, Ouyang J. Screening of the binding of small molecules to proteins by desorption electrospray ionization mass spectrometry combined with protein microarray. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2015; 26:1950-1958. [PMID: 26174365 DOI: 10.1007/s13361-015-1221-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/19/2015] [Revised: 06/18/2015] [Accepted: 06/19/2015] [Indexed: 06/04/2023]
Abstract
The interaction between bioactive small molecule ligands and proteins is one of the important research areas in proteomics. Herein, a simple and rapid method is established to screen small ligands that bind to proteins. We designed an agarose slide to immobilize different proteins. The protein microarrays were allowed to interact with different small ligands, and after washing, the microarrays were screened by desorption electrospray ionization mass spectrometry (DESI MS). This method can be applied to screen specific protein binding ligands and was shown for seven proteins and 34 known ligands for these proteins. In addition, a high-throughput screening was achieved, with the analysis requiring approximately 4 s for one sample spot. We then applied this method to determine the binding between the important protein matrix metalloproteinase-9 (MMP-9) and 88 small compounds. The molecular docking results confirmed the MS results, demonstrating that this method is suitable for the rapid and accurate screening of ligands binding to proteins. Graphical Abstract ᅟ.
Collapse
Affiliation(s)
- Chenxi Yao
- Key Laboratory of Theoretical and Computational Photochemistry, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, People's Republic of China
| | - Tao Wang
- Department of Pharmacy, Changzhi Medical College, Changzhi, 046000, People's Republic of China
| | - Buqing Zhang
- Key Laboratory of Theoretical and Computational Photochemistry, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, People's Republic of China
| | - Dacheng He
- Key Laboratory for Cell Proliferation and Regulation Biology, Ministry of Education Beijing Normal University, Beijing, 100875, People's Republic of China
| | - Na Na
- Key Laboratory of Theoretical and Computational Photochemistry, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, People's Republic of China
| | - Jin Ouyang
- Key Laboratory of Theoretical and Computational Photochemistry, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, People's Republic of China.
| |
Collapse
|
9
|
Electrochemical immunosensor for botulinum neurotoxin type-E using covalently ordered graphene nanosheets modified electrodes and gold nanoparticles-enzyme conjugate. Biosens Bioelectron 2015; 69:249-56. [DOI: 10.1016/j.bios.2015.02.039] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2014] [Revised: 02/13/2015] [Accepted: 02/25/2015] [Indexed: 01/19/2023]
|
10
|
Savage AC, Buckley N, Halliwell J, Gwenin C. Botulinum neurotoxin serotypes detected by electrochemical impedance spectroscopy. Toxins (Basel) 2015; 7:1544-55. [PMID: 25954998 PMCID: PMC4448162 DOI: 10.3390/toxins7051544] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2015] [Revised: 04/26/2015] [Accepted: 04/30/2015] [Indexed: 12/29/2022] Open
Abstract
Botulinum neurotoxin is one of the deadliest biological toxins known to mankind and is able to cause the debilitating disease botulism. The rapid detection of the different serotypes of botulinum neurotoxin is essential for both diagnosis of botulism and identifying the presence of toxin in potential cases of terrorism and food contamination. The modes of action of botulinum neurotoxins are well-established in literature and differ for each serotype. The toxins are known to specifically cleave portions of the SNARE proteins SNAP-25 or VAMP; an interaction that can be monitored by electrochemical impedance spectroscopy. This study presents a SNAP-25 and a VAMP biosensors for detecting the activity of five botulinum neurotoxin serotypes (A-E) using electrochemical impedance spectroscopy. The biosensors are able to detect concentrations of toxins as low as 25 fg/mL, in a short time-frame compared with the current standard methods of detection. Both biosensors show greater specificity for their compatible serotypes compared with incompatible serotypes and denatured toxins.
Collapse
Affiliation(s)
- Alison C Savage
- School of Chemistry, Bangor University, Bangor, Gwynedd, Wales LL57 2DG, UK.
| | - Nicholas Buckley
- School of Chemistry, Bangor University, Bangor, Gwynedd, Wales LL57 2DG, UK.
| | - Jennifer Halliwell
- School of Chemistry, Bangor University, Bangor, Gwynedd, Wales LL57 2DG, UK.
| | - Christopher Gwenin
- School of Chemistry, Bangor University, Bangor, Gwynedd, Wales LL57 2DG, UK.
| |
Collapse
|
11
|
Saravanan P, Rajaseger G, Eric YPH, Moochhala S. Botulinum Toxin: Present Knowledge and Threats. BIOLOGICAL TOXINS AND BIOTERRORISM 2015. [DOI: 10.1007/978-94-007-5869-8_3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
12
|
Jenko KL, Zhang Y, Kostenko Y, Fan Y, Garcia-Rodriguez C, Lou J, Marks JD, Varnum SM. Development of an ELISA microarray assay for the sensitive and simultaneous detection of ten biodefense toxins. Analyst 2014; 139:5093-102. [PMID: 25112421 PMCID: PMC6540756 DOI: 10.1039/c4an01270d] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Plant and microbial toxins are considered bioterrorism threat agents because of their extreme toxicity and/or ease of availability. Additionally, some of these toxins are increasingly responsible for accidental food poisonings. The current study utilized an ELISA-based protein antibody microarray for the multiplexed detection of ten biothreat toxins, botulinum neurotoxins (BoNT) A, B, C, D, E, F, ricin, shiga toxins 1 and 2 (Stx), and staphylococcus enterotoxin B (SEB), in buffer and complex biological matrices. The multiplexed assay displayed a sensitivity of 1.3 pg mL(-1) (BoNT/A, BoNT/B, SEB, Stx-1 and Stx-2), 3.3 pg mL(-1) (BoNT/C, BoNT/E, BoNT/F) and 8.2 pg mL(-1) (BoNT/D, ricin). All assays demonstrated high accuracy (75-120 percent recovery) and reproducibility (most coefficients of variation <20%). Quantification curves for the ten toxins were also evaluated in clinical samples (serum, plasma, nasal fluid, saliva, stool, and urine) and environmental samples (apple juice, milk and baby food) with overall minimal matrix effects. The multiplex assays were highly specific, with little cross-reactivity observed between the selected toxin antibodies. The results demonstrate a multiplex microarray that improves current immunoassay sensitivity for biological warfare agents in buffer, clinical, and environmental samples.
Collapse
Affiliation(s)
- Kathryn L Jenko
- Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Zhang Z, Yu L, Xu L, Hu X, Li P, Zhang Q, Ding X, Feng X. Biotoxin sensing in food and environment via microchip. Electrophoresis 2014; 35:1547-59. [PMID: 24723235 DOI: 10.1002/elps.201300570] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2013] [Revised: 02/21/2014] [Accepted: 03/20/2014] [Indexed: 12/23/2022]
Affiliation(s)
- Zhaowei Zhang
- Oil Crops Research Institute; Chinese Academy of Agricultural Sciences; Wuhan China
- Key Laboratory of Biology and Genetic Improvement of Oil Crops; Ministry of Agriculture; Wuhan China
| | - Li Yu
- Oil Crops Research Institute; Chinese Academy of Agricultural Sciences; Wuhan China
- Laboratory of Risk Assessment for Oilseeds Products (Wuhan); Ministry of Agriculture; Wuhan China
| | - Lin Xu
- Oil Crops Research Institute; Chinese Academy of Agricultural Sciences; Wuhan China
- Quality Inspection and Test Center for Oilseeds Products; Ministry of Agriculture; Wuhan China
| | - Xiaofeng Hu
- Oil Crops Research Institute; Chinese Academy of Agricultural Sciences; Wuhan China
- Key Laboratory of Detection for Mycotoxins; Ministry of Agriculture; Wuhan China
| | - Peiwu Li
- Oil Crops Research Institute; Chinese Academy of Agricultural Sciences; Wuhan China
- Key Laboratory of Biology and Genetic Improvement of Oil Crops; Ministry of Agriculture; Wuhan China
- Laboratory of Risk Assessment for Oilseeds Products (Wuhan); Ministry of Agriculture; Wuhan China
- Quality Inspection and Test Center for Oilseeds Products; Ministry of Agriculture; Wuhan China
- Key Laboratory of Detection for Mycotoxins; Ministry of Agriculture; Wuhan China
| | - Qi Zhang
- Oil Crops Research Institute; Chinese Academy of Agricultural Sciences; Wuhan China
- Key Laboratory of Biology and Genetic Improvement of Oil Crops; Ministry of Agriculture; Wuhan China
| | - Xiaoxia Ding
- Key Laboratory of Biology and Genetic Improvement of Oil Crops; Ministry of Agriculture; Wuhan China
- Laboratory of Risk Assessment for Oilseeds Products (Wuhan); Ministry of Agriculture; Wuhan China
| | - Xiaojun Feng
- Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics and Molecular Imaging Key Laboratory; Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology; Huazhong University of Science and Technology; Wuhan China
| |
Collapse
|
14
|
Detection and quantification of lysine acetyl-alteration using antibody microarray. Bioanalysis 2014; 5:2469-80. [PMID: 24138621 DOI: 10.4155/bio.13.191] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Lysine acetylation is a reversible and dynamic post-translational modification on proteins, and plays an important role in diverse biological processes. Technological limitations have so far prevented comparative quantification of lysine acetylation in different samples. RESULTS We developed a method to efficiently study lysine acetylation on individual proteins from complex mixtures, using antibody microarrays to capture individual proteins followed by detection with lysine acetyl antibody. By profiling both protein and acetylation variations in multiple samples using this microarray, we found cancer-associated lysine acetylation alteration on VEGF in the serum of hepatocellular carcinoma patients. CONCLUSION Microarrays of lysine acetylation are highly effective for detecting acetylation, and should be useful in identifying and validating disease-associated acetylation alterations as biomarkers under both normal and pathological circumstances.
Collapse
|
15
|
Liu Y, Yu F, Huang H, Han J. Development of recombinant antigen array for simultaneous detection of viral antibodies. PLoS One 2013; 8:e73842. [PMID: 24058498 PMCID: PMC3772810 DOI: 10.1371/journal.pone.0073842] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2013] [Accepted: 07/30/2013] [Indexed: 01/01/2023] Open
Abstract
Protein microarrays have been developed to study antibody reactivity against a large number of antigens, demonstrating extensive perspective for clinical application. We developed a viral antigen array by spotting four recombinant antigens and synthetic peptide, including glycoprotein G of herpes simplex virus (HSV) type 1 and 2, phosphoprotein 150 of cytomegalovirus (CMV), Rubella virus (RV) core plus glycoprotein E1 and E2 as well as a E1 peptide with the optimal concentrations on activated glass slides to simultaneously detect IgG and IgM against HSV1, HSV2, CMV and RV in clinical specimens of sera and cerebrospinal fluids (CSFs). The positive reference sera were initially used to measure the sensitivity and specificity of the array with the optimal conditions. Then clinical specimens of 144 sera and 93 CSFs were tested for IgG and IgM antibodies directed against HSV1, HSV2, CMV and RV by the antigen array. Specificity of the antigen array for viral antibodies detection was satisfying compared to commercial ELISA kits but sensitivity of the array varied relying on quality and antigenic epitopes of the spotting antigens. In short, the recombinant antigen array has potential to simultaneous detect multiple viral antibodies using minute amount (3 µl) of samples, which holds the particularly advantage to detect viral antibodies in clinical CSFs being suspicious of neonatal meningitis and encephalitis.
Collapse
Affiliation(s)
- Yi Liu
- Pediatric Research Institute, Qilu Children’s Hospital of Shandong University, Ji’nan, China
| | - Fengling Yu
- Clinical Laboratory, Qilu Children’s Hospital of Shandong University, Ji’nan, China
| | - Haiyan Huang
- Key Laboratory for Biotech-Drugs of the Ministry of Health, Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences, Ji’nan, China
| | - Jinxiang Han
- Key Laboratory for Biotech-Drugs of the Ministry of Health, Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences, Ji’nan, China
- * E-mail:
| |
Collapse
|
16
|
Jones RGA, Marks JD. Use of a new functional dual coating (FDC) assay to measure low toxin levels in serum and food samples following an outbreak of human botulism. J Med Microbiol 2013; 62:828-835. [DOI: 10.1099/jmm.0.053124-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
Clostridium
botulinum type A toxin is the most prevalent cause of naturally occurring outbreaks of human botulism in the world. The active dichain neurotoxin molecule is composed of a heavy chain (H-chain) of ~100 kDa with the carboxy-terminal end consisting of a receptor-binding (HC) domain, while the amino-terminal (HN) domain is linked by a critical disulfide bond to a light chain (L-chain) of ~50 kDa. Although the mouse bioassay (MBA) is traditionally used to confirm the presence of toxin in serum or food, its sensitivity is insufficient to detect low toxin levels in approximately 30 to 60 % of botulism patients. A novel FDC (functional dual coating) microtitre plate immuno-biochemical assay, which quantifies botulinum toxicity by measuring the HC domain linked with L-chain endopeptidase activity, was modified to allow human serum (lysed or unlysed) to be tested without interference from the matrix, with toxin detection down to 0.03 mouse LD50 per ml serum or 0.13 pg ml–1 using just 100 µl of clinical samples. The assay was specific for type A toxin and could additionally be applied to whole blood and food samples. Low levels of 1 to 2 mouse LD50 per ml serum of type A toxin were quantified for the first time using the modified FDC assay in two severely intoxicated UK patients who required mechanical ventilation and antitoxin. Toxin levels in recovered food sample extracts were also detected and one MBA-negative sample was found to contain 0.32 LD50 per ml extract. The FDC assay provides a real alternative for public health laboratories to unambiguously confirm all cases of type A botulism and, due to its sensitivity, a promising new tool in toxin pharmacokinetic studies.
Collapse
Affiliation(s)
- Russell G. A. Jones
- Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Hertfordshire, UK
| | - James D. Marks
- Department of Anesthesia, University of California, San Francisco, USA
| |
Collapse
|
17
|
Endom EE. Bioterrorism and the Pediatric Patient: An Update. CLINICAL PEDIATRIC EMERGENCY MEDICINE 2013. [DOI: 10.1016/j.cpem.2013.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|